{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T06:47:47Z","timestamp":1778309267462,"version":"3.51.4"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"S2","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Genomics"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/1471-2164-16-s2-s14","type":"journal-article","created":{"date-parts":[[2015,6,18]],"date-time":"2015-06-18T10:16:31Z","timestamp":1434622591000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Mechanistic analysis elucidating the relationship between Lys96 mutation in Mycobacterium tuberculosispyrazinamidase enzyme and pyrazinamide susceptibility"],"prefix":"10.1186","volume":"16","author":[{"given":"Chakshu","family":"Vats","sequence":"first","affiliation":[]},{"given":"Jaspreet Kaur","family":"Dhanjal","sequence":"additional","affiliation":[]},{"given":"Sukriti","family":"Goyal","sequence":"additional","affiliation":[]},{"given":"Ankita","family":"Gupta","sequence":"additional","affiliation":[]},{"given":"Navneeta","family":"Bharadvaja","sequence":"additional","affiliation":[]},{"given":"Abhinav","family":"Grover","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2015,1,21]]},"reference":[{"issue":"1","key":"6966_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/0974-777X.77287","volume":"3","author":"RO Onyango","year":"2011","unstructured":"Onyango RO: State of the Globe: Tracking Tuberculosis is the Test of Time. J Glob Infect Dis. 2011, 3 (1): 1-3. 10.4103\/0974-777X.77287.","journal-title":"J Glob Infect Dis"},{"issue":"Suppl 1","key":"6966_CR2","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1016\/j.tube.2011.10.010","volume":"91","author":"K McQuade Billingsley","year":"2011","unstructured":"McQuade Billingsley K, Smith N, Shirley R, Achieng L, Keiser P: A quality assessment tool for tuberculosis control activities in resource limited settings. Tuberculosis. 2011, 91 (Suppl 1): S49-53.","journal-title":"Tuberculosis"},{"issue":"7","key":"6966_CR3","first-page":"564","volume":"3","author":"LB Heifets","year":"1999","unstructured":"Heifets LB, Cangelosi GA: Drug susceptibility testing of Mycobacterium tuberculosis: a neglected problem at the turn of the century. The international journal of tuberculosis and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease. 1999, 3 (7): 564-581.","journal-title":"The international journal of tuberculosis and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease"},{"issue":"4","key":"6966_CR4","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1093\/cid\/cis487","volume":"55","author":"KE Dooley","year":"2012","unstructured":"Dooley KE, Mitnick CD, Ann DeGroote M, Obuku E, Belitsky V, Hamilton CD, Makhene M, Shah S, Brust JC, Durakovic N, et al: Old drugs, new purpose: retooling existing drugs for optimized treatment of resistant tuberculosis. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2012, 55 (4): 572-581. 10.1093\/cid\/cis487.","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America"},{"issue":"4","key":"6966_CR5","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.bbrc.2013.03.013","volume":"433","author":"H Dhiman","year":"2013","unstructured":"Dhiman H, Dhanjal JK, Sharma S, Chacko S, Grover S, Grover A: Resisting resistant Mycobacterium tuberculosis naturally: mechanistic insights into the inhibition of the parasite's sole signal peptidase Leader peptidase B. Biochem Biophys Res Commun. 2013, 433 (4): 552-557. 10.1016\/j.bbrc.2013.03.013.","journal-title":"Biochem Biophys Res Commun"},{"issue":"Suppl 1","key":"6966_CR6","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1186\/1471-2164-15-S1-S3","volume":"15","author":"JK Dhanjal","year":"2014","unstructured":"Dhanjal JK, Grover S, Sharma S, Singh A, Grover A: Structural insights into mode of actions of novel natural Mycobacterium protein tyrosine phosphatase B inhibitors. BMC Genomics. 2014, 15 (Suppl 1): S3-10.1186\/1471-2164-15-S1-S3.","journal-title":"BMC Genomics"},{"key":"6966_CR7","doi-asserted-by":"publisher","first-page":"979606","DOI":"10.1155\/2014\/979606","volume":"2014","author":"M Goyal","year":"2014","unstructured":"Goyal M, Dhanjal JK, Goyal S, Tyagi C, Hamid R, Grover A: Development of dual inhibitors against Alzheimer's disease using fragment-based QSAR and molecular docking. Biomed Res Int. 2014, 2014: 979606-","journal-title":"Biomed Res Int"},{"issue":"4","key":"6966_CR8","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1007\/s00044-013-0810-2","volume":"23","author":"M Goyal","year":"2014","unstructured":"Goyal M, Grover S, Dhanjal JK, Goyal S, Tyagi C, Grover A: Molecular modelling studies on flavonoid derivatives as dual site inhibitors of human acetyl cholinesterase using 3D-QSAR, pharmacophore and high throughput screening approaches. Medicinal Chemistry Research. 2014, 23 (4): 2122-2132. 10.1007\/s00044-013-0810-2.","journal-title":"Medicinal Chemistry Research"},{"issue":"4","key":"6966_CR9","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1186\/1756-0500-7-446","volume":"7","author":"S Soni","year":"2014","unstructured":"Soni S, Tyagi C, Grover A, Goswami SK: Molecular modeling and molecular dynamics simulations based structural analysis of the SG2NA protein variants. BMC Res Notes. 2014, 7 (4): 446-","journal-title":"BMC Res Notes"},{"issue":"4","key":"6966_CR10","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1016\/S0140-6736(09)60331-7","volume":"373","author":"A Wright","year":"2009","unstructured":"Wright A, Zignol M, Van Deun A, Falzon D, Gerdes SR, Feldman K, Hoffner S, Drobniewski F, Barrera L, van Soolingen D, et al: Epidemiology of antituberculosis drug resistance 2002-07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Lancet. 2009, 373 (4): 1861-1873.","journal-title":"Lancet"},{"issue":"4","key":"6966_CR11","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1164\/ajrccm\/145.5.1223","volume":"145","author":"L Heifets","year":"1992","unstructured":"Heifets L, Lindholm-Levy P: Pyrazinamide sterilizing activity in vitro against semidormant Mycobacterium tuberculosis bacterial populations. Am Rev Respir Dis. 1992, 145 (4): 1223-1225.","journal-title":"Am Rev Respir Dis"},{"issue":"4","key":"6966_CR12","doi-asserted-by":"publisher","first-page":"4499","DOI":"10.1128\/AAC.00630-11","volume":"55","author":"KC Chang","year":"2011","unstructured":"Chang KC, Yew WW, Zhang Y: Pyrazinamide susceptibility testing in Mycobacterium tuberculosis: a systematic review with meta-analyses. Antimicrob Agents Chemother. 2011, 55 (4): 4499-4505.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"6966_CR13","first-page":"461","volume":"95","author":"K Konno","year":"1967","unstructured":"Konno K, Feldmann FM, McDermott W: Pyrazinamide susceptibility and amidase activity of tubercle bacilli. Am Rev Respir Dis. 1967, 95 (4): 461-469.","journal-title":"Am Rev Respir Dis"},{"issue":"4","key":"6966_CR14","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1111\/j.1742-4658.2007.06241.x","volume":"275","author":"H Zhang","year":"2008","unstructured":"Zhang H, Deng JY, Bi LJ, Zhou YF, Zhang ZP, Zhang CG, Zhang Y, Zhang XE: Characterization of Mycobacterium tuberculosis nicotinamidase\/ pyrazinamidase. FEBS J. 2008, 275 (4): 753-762. 10.1111\/j.1742-4658.2007.06241.x.","journal-title":"FEBS J"},{"issue":"4","key":"6966_CR15","first-page":"523","volume":"65","author":"RL Yeager","year":"1952","unstructured":"Yeager RL, Munroe WG, Dessau FI: Pyrazinamide (aldinamide) in the treatment of pulmonary tuberculosis. Am Rev Tuberc. 1952, 65 (4): 523-546.","journal-title":"Am Rev Tuberc"},{"issue":"4","key":"6966_CR16","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1128\/AAC.41.3.540","volume":"41","author":"A Scorpio","year":"1997","unstructured":"Scorpio A, Lindholm-Levy P, Heifets L, Gilman R, Siddiqi S, Cynamon M, Zhang Y: Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis. Antimicrob Agents Chemother. 1997, 41 (4): 540-543.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"6966_CR17","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1128\/AAC.44.9.2291-2295.2000","volume":"44","author":"GP Morlock","year":"2000","unstructured":"Morlock GP, Crawford JT, Butler WR, Brim SE, Sikes D, Mazurek GH, Woodley CL, Cooksey RC: Phenotypic characterization of pncA mutants of Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2000, 44 (4): 2291-2295.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"6966_CR18","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1128\/AAC.00110-08","volume":"52","author":"P Jureen","year":"2008","unstructured":"Jureen P, Werngren J, Toro JC, Hoffner S: Pyrazinamide resistance and pncA gene mutations in Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2008, 52 (4): 1852-1854.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"6966_CR19","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1128\/AAC.43.7.1761","volume":"43","author":"N Lemaitre","year":"1999","unstructured":"Lemaitre N, Sougakoff W, Truffot-Pernot C, Jarlier V: Characterization of new mutations in pyrazinamide-resistant strains of Mycobacterium tuberculosis and identification of conserved regions important for the catalytic activity of the pyrazinamidase PncA. Antimicrob Agents Chemother. 1999, 43 (4): 1761-1763.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"6966_CR20","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1128\/AAC.41.3.636","volume":"41","author":"S Sreevatsan","year":"1997","unstructured":"Sreevatsan S, Pan X, Zhang Y, Kreiswirth BN, Musser JM: Mutations associated with pyrazinamide resistance in pncA of Mycobacterium tuberculosis complex organisms. Antimicrob Agents Chemother. 1997, 41 (4): 636-640.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"6966_CR21","doi-asserted-by":"publisher","first-page":"153","DOI":"10.4269\/ajtmh.2012.10-0565","volume":"87","author":"P Sheen","year":"2012","unstructured":"Sheen P, Ferrer P, Gilman RH, Christiansen G, Moreno-Roman P, Gutierrez AH, Sotelo J, Evangelista W, Fuentes P, Rueda D, et al: Role of metal ions on the activity of Mycobacterium tuberculosis pyrazinamidase. Am J Trop Med Hyg. 2012, 87 (4): 153-161.","journal-title":"Am J Trop Med Hyg"},{"issue":"4","key":"6966_CR22","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1080\/00313020903071587","volume":"41","author":"S Pandey","year":"2009","unstructured":"Pandey S, Newton S, Upton A, Roberts S, Drinkovic D: Characterisation of pncA mutations in clinical Mycobacterium tuberculosis isolates in New Zealand. Pathology. 2009, 41 (4): 582-584.","journal-title":"Pathology"},{"issue":"4","key":"6966_CR23","doi-asserted-by":"publisher","first-page":"335","DOI":"10.6026\/97320630006335","volume":"6","author":"M Quiliano","year":"2011","unstructured":"Quiliano M, Gutierrez AH, Gilman RH, Lopez C, Evangelista W, Sotelo J, Sheen P, Zimic M: Structure-Activity relationship in mutated pyrazinamidases from Mycobacterium tuberculosis. Bioinformation. 2011, 6 (4): 335-339.","journal-title":"Bioinformation"},{"issue":"4","key":"6966_CR24","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1080\/07391102.2012.759885","volume":"32","author":"V Rajendran","year":"2014","unstructured":"Rajendran V, Sethumadhavan R: Drug resistance mechanism of PncA in Mycobacterium tuberculosis. Journal of biomolecular structure & dynamics. 2014, 32 (4): 209-221.","journal-title":"Journal of biomolecular structure & dynamics"},{"issue":"4","key":"6966_CR25","doi-asserted-by":"publisher","first-page":"e15785","DOI":"10.1371\/journal.pone.0015785","volume":"6","author":"S Petrella","year":"2011","unstructured":"Petrella S, Gelus-Ziental N, Maudry A, Laurans C, Boudjelloul R, Sougakoff W: Crystal structure of the pyrazinamidase of Mycobacterium tuberculosis: insights into natural and acquired resistance to pyrazinamide. PLoS One. 2011, 6 (4): e15785-","journal-title":"PLoS One"},{"issue":"4","key":"6966_CR26","doi-asserted-by":"publisher","first-page":"14166","DOI":"10.1021\/bi0115479","volume":"40","author":"X Du","year":"2001","unstructured":"Du X, Wang W, Kim R, Yakota H, Nguyen H, Kim SH: Crystal structure and mechanism of catalysis of a pyrazinamidase from Pyrococcus horikoshii. Biochemistry. 2001, 40 (4): 14166-14172.","journal-title":"Biochemistry"},{"issue":"Pt 3","key":"6966_CR27","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1042\/bj3530453","volume":"353","author":"N Lemaitre","year":"2001","unstructured":"Lemaitre N, Callebaut I, Frenois F, Jarlier V, Sougakoff W: Study of the structure-activity relationships for the pyrazinamidase (PncA) from Mycobacterium tuberculosis. Biochem J. 2001, 353 (Pt 3): 453-458.","journal-title":"Biochem J"},{"issue":"4","key":"6966_CR28","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1054\/tuld.1998.0002","volume":"79","author":"S Ramaswamy","year":"1998","unstructured":"Ramaswamy S, Musser JM: Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tubercle and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease. 1998, 79 (4): 3-29.","journal-title":"Tubercle and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease"},{"issue":"4","key":"6966_CR29","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1093\/cid\/cit811","volume":"58","author":"LT Daum","year":"2014","unstructured":"Daum LT, Fourie PB, Bhattacharyya S, Ismail NA, Gradus S, Maningi NE, Omar SV, Fischer GW: Next-generation sequencing for identifying pyrazinamide resistance in Mycobacterium tuberculosis. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2014, 58 (4): 903-904.","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America"},{"issue":"4","key":"6966_CR30","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1093\/jac\/dkr173","volume":"66","author":"PE Almeida Da Silva","year":"2011","unstructured":"Almeida Da Silva PE, Palomino JC: Molecular basis and mechanisms of drug resistance in Mycobacterium tuberculosis: classical and new drugs. J Antimicrob Chemother. 2011, 66 (4): 1417-1430.","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"6966_CR31","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1007\/s00894-010-0785-6","volume":"17","author":"R Purohit","year":"2011","unstructured":"Purohit R, Rajendran V, Sethumadhavan R: Relationship between mutation of serine residue at 315th position in M. tuberculosis catalase-peroxidase enzyme and Isoniazid susceptibility: an in silico analysis. J Mol Model. 2011, 17 (4): 869-877. 10.1007\/s00894-010-0785-6.","journal-title":"J Mol Model"},{"issue":"Pt 6 No 1","key":"6966_CR32","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1107\/S0907444902003451","volume":"58","author":"HM Berman","year":"2002","unstructured":"Berman HM, Battistuz T, Bhat TN, Bluhm WF, Bourne PE, Burkhardt K, Feng Z, Gilliland GL, Iype L, Jain S, et al: The Protein Data Bank. Acta Crystallogr D Biol Crystallogr. 2002, 58 (Pt 6 No 1): 899-907.","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"issue":"4","key":"6966_CR33","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/j.1600-0773.1987.tb01740.x","volume":"60","author":"L Stahle","year":"1987","unstructured":"Stahle L, Ljungberg T, Rodebjer A, Ogren SO, Ungerstedt U: Differential effects of the dopamine antagonist remoxipride on apomorphine induced behaviour in the rat. Pharmacol Toxicol. 1987, 60 (4): 227-232.","journal-title":"Pharmacol Toxicol"},{"issue":"Database","key":"6966_CR34","doi-asserted-by":"publisher","first-page":"D901","DOI":"10.1093\/nar\/gkm958","volume":"36","author":"DS Wishart","year":"2008","unstructured":"Wishart DS, Knox C, Guo AC, Cheng D, Shrivastava S, Tzur D, Gautam B, Hassanali M: DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res. 2008, 36 (Database): D901-906.","journal-title":"Nucleic Acids Res"},{"key":"6966_CR35","doi-asserted-by":"publisher","first-page":"W116","DOI":"10.1093\/nar\/gkl282","volume":"34","author":"ZO Joe Dundas","year":"2006","unstructured":"Joe Dundas ZO, Tseng Jeffery, Binkowski Andrew, Turpaz Yaron, Liang Jie: CASTp: computed atlas of surface topography of proteins with structural and topographical mapping of functionally annotated resiudes. Nucleic Acids Res. 2006, 34: W116-W118. 10.1093\/nar\/gkl282.","journal-title":"Nucleic Acids Res"},{"key":"6966_CR36","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1758-2946-5-39","volume":"5","author":"D Sehnal","year":"2013","unstructured":"Sehnal D, Varekov\u00e1 RS, Berka K, Pravda L, Navr\u00e1tilov\u00e1 V, Ban\u00e1s P, Ionescu C-M, Otyepka M, Koca J: MOLE 2.0: advanced approach for analysis of biomacromolecular channels. J Cheminformatics. 2013, 5: 39-10.1186\/1758-2946-5-39.","journal-title":"J Cheminformatics"},{"issue":"4","key":"6966_CR37","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1021\/jm0306430","volume":"47","author":"RA Friesner","year":"2004","unstructured":"Friesner RA, Banks JL, Murphy RB, Halgren TA, Klicic JJ, Mainz DT, Repasky MP, Knoll EH, Shelley M, Perry JK, et al: Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem. 2004, 47 (4): 1739-1749.","journal-title":"J Med Chem"},{"key":"6966_CR38","unstructured":"Small-Molecule Drug Discovery Suite 2013-1: Glide v. 2013, Schr\u00f6dinger, LLC, New York, NY"},{"issue":"4","key":"6966_CR39","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","volume":"27","author":"G Madhavi Sastry","year":"2013","unstructured":"Madhavi Sastry G, Adzhigirey M, Day T, Annabhimoju R, Sherman W: Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments. J Comput Aided Mol Des. 2013, 27 (4): 221-234.","journal-title":"J Comput Aided Mol Des"},{"key":"6966_CR40","unstructured":"Schr\u00f6dinger Release 2013-1: Schr\u00f6dinger Suite 2013 Protein Preparation Wizard; Epik version 2.4. 2013, S, LLC, New York, NY, Impact version 5.9, Schr\u00f6dinger, LLC, New York, NY, 2013; Prime version 3.2, Schr\u00f6dinger, LLC, New York, NY, 2013"},{"key":"6966_CR41","doi-asserted-by":"crossref","unstructured":"Schr\u00f6dinger Release 2013-1: LigPrep v. 2013, Schr\u00f6dinger, LLC, New York, NY","DOI":"10.1155\/2013\/170835"},{"issue":"4","key":"6966_CR42","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1073\/pnas.93.1.13","volume":"93","author":"S Jones","year":"1996","unstructured":"Jones S, Thornton JM: Principles of protein-protein interactions. Proc Natl Acad Sci USA. 1996, 93 (4): 13-20.","journal-title":"Proc Natl Acad Sci USA"},{"key":"6966_CR43","doi-asserted-by":"crossref","unstructured":"Schneidman-Duhovny D, Inbar Y, Nussinov R, Wolfson HJ: PatchDock and SymmDock: servers for rigid and symmetric docking. Nucleic Acids Res. 2005, W363-367. 33 Web Server","DOI":"10.1093\/nar\/gki481"},{"key":"6966_CR44","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/3-540-45784-4_14","volume-title":"Algorithms in bioinformatics","author":"D Duhovny","year":"2002","unstructured":"Duhovny D, Nussinov R, Wolfson HJ: Efficient unbound docking of rigid molecules. Algorithms in bioinformatics. 2002, Springer, 185-200."},{"key":"6966_CR45","doi-asserted-by":"crossref","unstructured":"Grosdidier A, Zoete V, Michielin O: SwissDock, a protein-small molecule docking web service based on EADock DSS. Nucleic Acids Res. 2011, W270-277. 39 Web Server","DOI":"10.1093\/nar\/gkr366"},{"issue":"4","key":"6966_CR46","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1021\/ct900587b","volume":"6","author":"D Shivakumar","year":"2010","unstructured":"Shivakumar D, Williams J, Wu Y, Damm W, Shelley J, Sherman W: Prediction of Absolute Solvation Free Energies using Molecular Dynamics Free Energy Perturbation and the OPLS Force Field. J Chem Theory Comput. 2010, 6 (4): 1509-1519.","journal-title":"J Chem Theory Comput"},{"key":"6966_CR47","unstructured":"Schr\u00f6dinger Release 2013-1: Desmond Molecular Dynamics System v, D. E. 2013, Shaw Research, New York, NY, Maestro-Desmond Interoperability Tools, version 3.4, Schr\u00f6dinger, New York, NY, 2013"},{"issue":"4","key":"6966_CR48","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1093\/protein\/8.2.127","volume":"8","author":"LR Wallace AC","year":"1995","unstructured":"Wallace AC LR: LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. Protein Eng. 1995, 8 (4): 127-134.","journal-title":"Protein Eng"}],"container-title":["BMC Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2164-16-S2-S14.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,14]],"date-time":"2022-05-14T00:00:27Z","timestamp":1652486427000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgenomics.biomedcentral.com\/articles\/10.1186\/1471-2164-16-S2-S14"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,21]]},"references-count":48,"journal-issue":{"issue":"S2","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["6966"],"URL":"https:\/\/doi.org\/10.1186\/1471-2164-16-s2-s14","relation":{},"ISSN":["1471-2164"],"issn-type":[{"value":"1471-2164","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,21]]},"assertion":[{"value":"21 January 2015","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"S14"}}